|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.68 CNY | -2.91% |
|
+5.64% | -5.33% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Chart calendar DaShenLin Pharmaceutical Group Co., Ltd.
Upcoming events on DaShenLin Pharmaceutical Group Co., Ltd.
No events available
Past events on DaShenLin Pharmaceutical Group Co., Ltd.
| 2026-05-18 | Earnings presentation | 04:00 |
| 2026-05-17 | Annual General Meeting | 21:00 |
| 2026-04-24 | Earnings release - Annual 2025 | |
| 2026-04-24 | Earnings release - Q1 2026 | |
| 2026-03-29 | Extraordinary General Meeting | 22:00 |
| 2025-12-09 | Earnings presentation | 03:00 |
| 2025-11-20 | Extraordinary General Meeting | 21:00 |
| 2025-10-30 | Earnings release - Q3 2025 | |
| 2025-09-26 | Earnings presentation | 04:00 |
| 2025-09-14 | Extraordinary General Meeting | 22:30 |
| 2025-08-29 | Earnings release - Q2 2025 | |
| 2025-06-24 | Extraordinary General Meeting | 22:30 |
Past dividends on DaShenLin Pharmaceutical Group Co., Ltd.
| 2025-11-06 | Ex-dividend date - 0.34 CNY | 00:00 |
| 2025-06-19 | Ex-dividend date - 0.31 CNY | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 24 531 24 720 -0.76% | 26 497 26 779 -1.05% | 27 502 27 576 -0.27% | 29 969 | 33 013 | 36 680 |
|
EBITDA Million CNY | Released Forecast Spread | 2 119 2 532 -16.31% | 3 395 3 349 1.4% | 3 833 3 281 16.84% | 3 761 | 4 251 | 4 791 |
|
EBIT Million CNY | Released Forecast Spread | 1 632 1 868 -12.66% | 1 501 1 673 -10.32% | 2 038 1 881 8.36% | 2 278 | 2 621 | 2 993 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 1 628 1 807 -9.91% | 1 340 1 496 -10.42% | 1 849 1 702 8.66% | 2 195 | 2 508 | 2 897 |
|
Net income Million CNY | Released Forecast Spread | 1 166 1 303 -10.51% | 915 1 152 -20.57% | 1 235 1 186 4.15% | 1 485 | 1 702 | 1 954 |
|
EPS CNY | Released Forecast Spread | 1,03 1,15 -10.59% | 0,81 1,05 -23.07% | 1,08 1,04 4.26% | 1,30 | 1,49 | 1,72 |
| Announcement Date | 28/04/24 | 25/04/25 | 23/04/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 6 386 6 364 0.34% | 6 766 7 282 -7.09% | 6 956 7 159 -2.84% | 6 567 7 200 -8.79% | 6 546 6 554 -0.12% | 7 434 7 262 2.37% | 6 973 7 184 -2.93% | 7 250 | 7 301 | 7 915 | 7 854 | 8 019 | 8 019 | 8 500 | 8 274 |
|
EBITDA Million CNY | Released Forecast Spread | 851 | 613 | 827 | 882 | 791 | 682 | 1 066 | 996 | 943 | 781 | 1 103 | 1 262 | 1 214 | 738 | 1 054 |
|
EBIT Million CNY | Released Forecast Spread | 295 422 -30.2% | 230 | 650 | 476 403 18% | 410 330 24.26% | 502 226 122.08% | 710 692 2.64% | 469 | 566 | 508 | 650 | 857 | 809 | 333 | 633 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 278 384 -27.52% | 160 146 10% | 649 362 79.29% | 474 404 17.44% | 398 314 26.73% | 327 215 52.58% | 707 670 5.55% | 598 | 545 | 374 | 668 | 826 | 778 | 300 | 600 |
|
Net income Million CNY | Released Forecast Spread | 201 275 -27.16% | 56,6 75,8 -25.28% | 460 255 80.19% | 338 276 22.59% | 283 192 47% | 154 130 18.36% | 511 521 -1.87% | 423 | 370 | 205 | 474 | 619 | 571 | 81,0 | 378 |
|
EPS CNY | Released Forecast Spread | 0,18 0,24 -24.13% | 0,06 0,11 -44.88% | 0,40 0,31 29.85% | 0,30 0,24 22.92% | 0,25 0,18 39.3% | 0,13 0,08 59.55% | 0,45 0,44 3.26% | 0,28 | 0,32 | 0,23 | 0,38 | 0,43 | 0,40 | 0,30 | 0,33 |
| Announcement Date | 30/10/24 | 25/04/25 | 25/04/25 | 28/08/25 | 29/10/25 | 23/04/26 | 23/04/26 | - | - | - | - | - | - | - | - |
| 2026-06-17 | Ex-dividend date - 0.15919 ZAR | 00:00 | |
| 2026-06-18 | Annual General Meeting | ||
| 2026-06-18 | Ex-dividend date - 6.5 JPY | 00:00 | |
| 2026-06-21 | Sales and Revenue Release - Annual 2026 | ||
| 2026-06-26 | Extraordinary General Meeting | 04:00 | |
| 2026-06-28 | Annual General Meeting | 22:00 | |
| 2026-07-01 | Ex-dividend date - 2.58 ZAR | 00:00 | |
| 2026-07-05 | Ex-dividend date - 0.63 SAR | 00:00 | |
| 2026-07-17 | Earnings release - Q2 2026 | 01:30 | |
| 2026-07-17 | Earnings presentation | 03:30 |
Past sector events for DaShenLin Pharmaceutical Group Co., Ltd.
| 2026-06-03 | Annual General Meeting | 13:00 | |
| 2026-06-03 | Extraordinary General Meeting | 14:00 | |
| 2026-05-31 | Earnings release - Q1 2026 | ||
| 2026-05-29 | Earnings presentation | 04:00 | |
| 2026-05-29 | Ex-dividend date - 0.2 CNY | 00:00 | |
| 2026-05-27 | Ex-dividend date - 0.1 CNY | 00:00 | |
| 2026-05-27 | Ex-dividend date - 0.6 SEK | 00:00 | |
| 2026-05-26 | Annual General Meeting | 04:00 | |
| 2026-05-25 | Earnings presentation | 04:00 | |
| 2026-05-22 | Annual General Meeting | 02:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603233 Stock
- Calendar DaShenLin Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















